Share:
Post hoc analyses by estimated on-treatment serum EPA levels in the VASCEPA group suggest potentially reduced incidence of new heart failure and new heart failure requiring hospitalization with higher achieved serum EPA levels
Amarin to Webcast Discussion of Data Presented at ACC.21 Monday, May 17, 2021 at 4:30 p.m., Eastern Time
DUBLIN, Ireland and BRIDGEWATER, N.J., May 15, 2021 (GLOBE NEWSWIRE) Amarin Corporation plc (NASDAQ:AMRN) today announced the presentation of REDUCE-IT
® HEART FAILURE (HF) at ACC.21, the American College of Cardiology s 70th Annual Scientific Session, being held virtually from May 15 – 17, 2021. These new analyses supported by Amarin were presented on behalf of all authors by Deepak L. Bhatt, M.D., M.P.H., Brigham and Women s Hospital, Harvard Medical School, Boston, MA.
5 Diet Tips for People With Rheumatoid Arthritis Kimberly Goad
Food isn’t a cure-all for rheumatoid arthritis (RA), but it plays a surprisingly big role when it comes to managing the condition. Research, including a study published in 2020 in
Contemporary Clinical Trials Communications, shows that making smart diet decisions can help control the inflammation that wreaks havoc in the body. Of course, the same food choices won’t be “right” for everyone but these five tips may help put you on the right track.
Choose anti-inflammatory foods
This one could have been called: “Head to the produce section.” Fruits and vegetables are rich in natural antioxidants, which help stabilize molecules called free radicals that can trigger inflammation. They’re also packed with polyphenols, micronutrients thought to help lower C-reactive protein, a marker of inflammation.
This Q&A will stream on Facebook , YouTube, and on The Forum website.
India is experiencing a catastrophic surge of coronavirus cases more than 22.66 million confirmed cases with more than 240,000 deaths. What can be done to help the situation in India, as well as in other countries, especially those with limited resources and low vaccination rates? In this live Q&A, K. “Vish” Viswanath, Director of the Harvard Chan India Research Center, and Louise Ivers, Executive Director of the MGH Center for Global Health, talk with Reuters’ Kate Kelland about the devastating situation in India and the lessons offered for the rest of the world. Email your viewer questions to theforum@hsph.harvard.edu or post your questions to Facebook @ForumHSPH.
Published: May 07, 2021
-Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health-
SALT LAKE CITY (BUSINESS WIRE) Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of a $12M Series A offering of preferred stock. The additional members are
Robert S. Langer, an Institute Professor at MIT and the most cited engineer in history and 4th most cited individual in any field who has authored more than 1,500 scientific papers. He is also a co-founder and board member of Moderna.